Assignee
BIOCON LTD
IN·90 granted patents·27 pending applications·525 citations·filing 1998–2025
Top patents by PatentIndex Score
117 records- 0195US8815247B2Targeted/immunomodulatory fusion proteinsBIOCON LTD·Filed 2013·Granted Aug 26, 2014·27 cites·1 claims
- 0294US7425578B2Immunoregulatory compounds and derivatives and methods of treating diseases therewithBIOCON LTD·Filed 2006·Granted Sep 16, 2008·21 cites·20 claims
- 0393US7605123B2Fatty acid formulations for oral delivery of proteins and peptides, and uses thereofBIOCON LTD·Filed 2005·Granted Oct 20, 2009·25 cites·15 claims
- 0492US9758582B2Anti-CTLA4 antibody-TGF-βRII targeted/immunomodulatory fusion proteinsBIOCON LTD·Filed 2016·Granted Sep 12, 2017·8 cites·1 claims
- 0592US7662773B2Natriuretic compounds, conjugates, and uses thereofBIOCON LTD·Filed 2003·Granted Feb 16, 2010·33 cites·78 claims
- 0691US12049632B2Anti-EGFR1-PD1 targeted/immunomodulatory fusion proteinBIOCON LTD·Filed 2021·Granted Jul 30, 2024·1 cites·3 claims
- 0791US7470663B2Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making sameBIOCON LTD·Filed 2006·Granted Dec 30, 2008·13 cites·5 claims
- 0891US2025011794A1Targeted/immunomodulatory fusion proteins and methods for making sameBIOCON LTD·Filed 2024·Application pending·0 cites
- 0990US9670285B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2015·Granted Jun 6, 2017·7 cites·4 claims
- 1090US7875700B2Cation complexes of insulin compound conjugates, formulation and uses thereofBIOCON LTD·Filed 2005·Granted Jan 25, 2011·13 cites·82 claims
- 1190US7648962B2Natriuretic compounds, conjugates, and uses thereofBIOCON LTD·Filed 2004·Granted Jan 19, 2010·36 cites·61 claims
- 1290US7423014B2Insulin conjugates for treating diabetes mellitusBIOCON LTD·Filed 2005·Granted Sep 9, 2008·16 cites·8 claims
- 1389US11028399B2CTLA4/PD1 targeted/immunomodulatory fusion proteinsBIOCON LTD·Filed 2019·Granted Jun 8, 2021·2 cites·2 claims
- 1489US10669346B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2018·Granted Jun 2, 2020·2 cites·12 claims
- 1589US10000573B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2017·Granted Jun 19, 2018·6 cites·9 claims
- 1689US6664095B1Solid state fermentationBIOCON LTD·Filed 2000·Granted Dec 16, 2003·62 cites·24 claims
- 1788US9217037B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2013·Granted Dec 22, 2015·8 cites·2 claims
- 1887US2024417483A1Monoclonal antibody and a method thereofBIOCON LTD·Filed 2024·Application pending·0 cites
- 1986US11028168B2Use of a CD6 binding partner and method based thereonBIOCON LTD·Filed 2018·Granted Jun 8, 2021·3 cites·8 claims
- 2086US10766963B2Fusion immunomodulatory proteins and methods for making sameBIOCON LTD·Filed 2018·Granted Sep 8, 2020·3 cites·6 claims
- 2185US11981743B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2020·Granted May 14, 2024·1 cites·11 claims
- 2285US7361772B2Process for the production of atorvastatin calciumBIOCON LTD·Filed 2003·Granted Apr 22, 2008·17 cites·11 claims
- 2384US7872095B2Insulin-oligomer conjugates, formulations and uses thereofBIOCON LTD·Filed 2005·Granted Jan 18, 2011·5 cites·20 claims
- 2484US6867306B2Process for the synthesis of atorvastatin form v and phenylboronates as intermediate compoundsBIOCON LTD·Filed 2001·Granted Mar 15, 2005·33 cites·7 claims
- 2583US10385348B2Epidermal growth factor receptor targeted/immunomodulatory fusion proteins and methods of use for themBIOCON LTD·Filed 2017·Granted Aug 20, 2019·2 cites·8 claims
- 2683US10144934B2Targeted/TGF-ßRII fusion proteins and methods for making sameBIOCON LTD·Filed 2017·Granted Dec 4, 2018·2 cites·14 claims
- 2783US2025368743A1Fusion immunomodulatory proteins and methods for making sameBIOCON LTD·Filed 2025·Application pending·0 cites
- 2882US9809651B2Method of treating cancer with an EGFR targeted immunomodulatory fusion proteinBIOCON LTD·Filed 2016·Granted Nov 7, 2017·2 cites·6 claims
- 2981US9988456B2Fusion immunomodulatory proteins and methods for making sameBIOCON LTD·Filed 2014·Granted Jun 5, 2018·5 cites·5 claims
- 3081US2024058263A1Formulations of antibodyBIOCON LTD·Filed 2023·Application pending·0 cites
- 3180US9340617B2Targeted/immunomodulatory fusion proteins and methods for making sameBIOCON LTD·Filed 2014·Granted May 17, 2016·2 cites·1 claims
- 3279US9856502B2Methods for controlling fucosylation levels in proteinsBIOCON LTD·Filed 2014·Granted Jan 2, 2018·6 cites·5 claims
- 3378US7196059B2Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewithBIOCON LTD·Filed 2003·Granted Mar 27, 2007·9 cites·34 claims
- 3478US6197573B1Solid state fermentationBIOCON LTD·Filed 1998·Granted Mar 6, 2001·71 cites·70 claims
- 3577US7166571B2Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing sameBIOCON LTD·Filed 2003·Granted Jan 23, 2007·6 cites·132 claims
- 3676US7119119B2Immunoregulatory compounds and derivatives and methods of treating diseases therewithBIOCON LTD·Filed 2005·Granted Oct 10, 2006·1 cites·5 claims
- 3775US6573385B1Process for manufacturing simvastatin and novel intermediates thereofBIOCON LTD·Filed 2002·Granted Jun 3, 2003·8 cites·8 claims
- 3874US12351636B2Fusion immunomodulatory proteins and methods for making sameBIOCON LTD·Filed 2020·Granted Jul 8, 2025·0 cites·2 claims
- 3974US7473366B2Process for the purification of macrolidesBIOCON LTD·Filed 2003·Granted Jan 6, 2009·9 cites·10 claims
- 4073US10189899B2Use of a CD6 binding partner and method based thereonBIOCON LTD·Filed 2014·Granted Jan 29, 2019·2 cites·6 claims
- 4172US8048924B2Methods and compositions employing 4-aminophenylacetic acid compoundsBIOCON LTD·Filed 2005·Granted Nov 1, 2011·1 cites·13 claims
- 4271US6603022B1Process for manufacturing Simvastatin and novel intermediates thereofBIOCON LTD·Filed 2003·Granted Aug 5, 2003·6 cites·26 claims
- 4371US2019321285A1Formulations of antibodyBIOCON LTD·Filed 2018·Application pending·0 cites
- 4470US2021290525A1Formulations of antibodyBIOCON LTD·Filed 2020·Application pending·0 cites
- 4569US11242401B2Monoclonal antibody and a method of use for the treatment of lupusBIOCON LTD·Filed 2017·Granted Feb 8, 2022·1 cites·7 claims
- 4669US11060097B2Immunotherapy methods using anti-PD-L1 antibodies in combination with EGFR1 targeted-TGF-beta immunomodulatory fusion proteinsBIOCON LTD·Filed 2019·Granted Jul 13, 2021·0 cites·4 claims
- 4769US7635675B2Micro-particle fatty acid salt solid dosage formulations for therapeutic agentsBIOCON LTD·Filed 2004·Granted Dec 22, 2009·5 cites·24 claims
- 4869US7169889B1Insulin prodrugs hydrolyzable in vivo to yield peglylated insulinBIOCON LTD·Filed 2000·Granted Jan 30, 2007·2 cites·25 claims
- 4969US6927047B1Manufacture and purification of mycophenolic acidBIOCON LTD·Filed 2000·Granted Aug 9, 2005·5 cites·10 claims
- 5068US6709846B1Methods of producing esters of mycophenolateBIOCON LTD·Filed 1999·Granted Mar 23, 2004·15 cites·20 claims
Showing the top 50 of 117 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →